柳氮磺胺吡啶（水杨酸偶氮磺胺吡啶）治疗克罗恩病的临床疗效。一项对照双盲研究 - Suppr | 超能文献

[Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation].

作者信息

Anthonisen P, Bárány F, Folkenborg O, Holtz A, Jarnum S, Kristensen M, Riis P, Walan A, Worning H

出版信息

Ugeskr Laeger. 1974 Aug 5;136(32):1798-802.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation].柳氮磺胺吡啶（水杨酸偶氮磺胺吡啶）治疗克罗恩病的临床疗效。一项对照双盲研究

Ugeskr Laeger. 1974 Aug 5;136(32):1798-802.

2

The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study.柳氮磺胺吡啶（水杨酸偶氮磺胺吡啶）治疗克罗恩病的临床效果。一项对照双盲研究。

Scand J Gastroenterol. 1974;9(6):549-54.

3

A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.甲硝唑与柳氮磺胺吡啶治疗活动性克罗恩病的比较研究：瑞典克罗恩病合作研究。II. 结果。

Gastroenterology. 1982 Sep;83(3):550-62.

4

The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial.

Scand J Gastroenterol. 1978;13(2):161-7. doi: 10.3109/00365527809181743.

5

[Further controlled studies on the effectiveness of salazosulfapyridine in the treatment of Crohn disease].[柳氮磺胺吡啶治疗克罗恩病有效性的进一步对照研究]

Z Gastroenterol Verh. 1981 Jun;19:45-9.

6

[Prevention of recurrence by salazosulfapyridine (azulfidine) therapy in Crohn's disease. A double blind study].[柳氮磺胺吡啶（艾迪莎）治疗克罗恩病预防复发的双盲研究]

Verh Dtsch Ges Inn Med. 1976;82 Pt 1:930-2.

7

A trial of sulfasalazine as adjunctive therapy in Crohn's disease.

Gastroenterology. 1979 Oct;77(4 Pt 2):887-97.

8

Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease.

Scand J Gastroenterol. 1976;11(7):651-6.

9

How should we treat Crohn's disease?

N Engl J Med. 1980 May 1;302(18):1024-6. doi: 10.1056/NEJM198005013021809.

10

Azathioprine-related pancreatitis in patients with Crohn's disease.克罗恩病患者中与硫唑嘌呤相关的胰腺炎

Gastroenterology. 1979 Oct;77(4 Pt 2):883-6.

引用本文的文献

1

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.口服5-氨基水杨酸用于维持克罗恩病药物诱导的缓解。

Cochrane Database Syst Rev. 2016 Sep 28;9(9):CD003715. doi: 10.1002/14651858.CD003715.pub3.

2

Aminosalicylates for induction of remission or response in Crohn's disease.用于诱导克罗恩病缓解或反应的氨基水杨酸盐。

Cochrane Database Syst Rev. 2016 Jul 3;7(7):CD008870. doi: 10.1002/14651858.CD008870.pub2.